Bupropion Hydrochloride — manufacturers, supply & price · Pillstats

Who makes it26 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Bryant Ranch Prepack	repackager	45	SUPPLYING
Proficient Rx LP	unknown	28	SUPPLYING
ScieGen Pharmaceuticals, Inc.	unknown	23	SUPPLYING
Dr.Reddy's laboratories Limited	unknown	20	SUPPLYING
A-S Medication Solutions	unknown	18	SUPPLYING
Preferred Pharmaceuticals, Inc.	unknown	15	SUPPLYING
SOLCO HEALTHCARE US, LLC	unknown	13	SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.	unknown	12	SUPPLYING
Radha Pharmaceuticals, Inc.	unknown	11	SUPPLYING
Granules Pharmaceuticals Inc	unknown	9	SUPPLYING
Actavis Pharma, Inc.	unknown	9	SUPPLYING
REMEDYREPACK INC.	repackager	8	SUPPLYING
Aphena Pharma Solutions - Tennessee, LLC	unknown	8	SUPPLYING
Northwind Health Company, LLC	unknown	7	SUPPLYING
Aurobindo Pharma Limited	unknown	6	SUPPLYING

+ 12 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Nov 22, 2023
RECALLRecall (Class III): buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutica…
Failed Dissolution Specifications — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide
Oct 4, 2023
RECALLRecall (Class III): Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by: Sun Phar…
Failed Dissolution Specifications — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.
May 9, 2023
RECALLRecall (Class II): buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceut…
Failed Dissolution Specifications; during stability testing — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the U.S.A
Apr 29, 2022
RECALLRecall (Class III): buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottle (47335-737-86), b)100-…
Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA
Apr 29, 2022
RECALLRecall (Class III): buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmac…
Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA
Dec 20, 2016
RECALLRecall (Class III): buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88)…
Failed Dissolution Specifications; 18 month stability time point — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide
Sep 13, 2016
RECALLRecall (Class III): buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distribu…
Failed Dissolution Specifications — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide
Jun 27, 2016
RECALLRecall (Class III): buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical I…
Failed Dissolution Specifications — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide
Jul 17, 2015
RECALLRecall (Class III): buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed…
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications. — Recalling firm: Sun Pharma Global Fze — Nationwide and Puerto Rico
Nov 15, 2013
RECALLRecall (Class III): BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count …
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months. — Recalling firm: Actavis Inc — Nationwide and Puerto Rico

Bupropion Hydrochloride

US acquisition costNADAC · per unit

Medicaid dispensing volumeSDUD · per quarter

Who makes it26 active · 1 exited

Regulatory & supply eventsFDA · US